CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
10.13
-0.69 (-6.38%)
At close: Feb 21, 2025, 4:00 PM
10.20
+0.07 (0.69%)
After-hours: Feb 21, 2025, 7:08 PM EST
CorMedix Employees
As of December 31, 2023, CorMedix had 83 total employees, including 82 full-time and 1 part-time employees. The number of employees increased by 42 or 102.44% compared to the previous year.
Employees
83
Change (1Y)
42
Growth (1Y)
102.44%
Revenue / Employee
$147,738
Profits / Employee
-$556,005
Market Cap
614.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CRMD News
- 6 weeks ago - CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update - GlobeNewsWire
- 2 months ago - CorMedix Inc. Added to Nasdaq Biotechnology Index - GlobeNewsWire
- 3 months ago - CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products - GlobeNewsWire
- 3 months ago - Stock Picks From Seeking Alpha's October 2024 New Analysts - Seeking Alpha
- 3 months ago - CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium - GlobeNewsWire
- 4 months ago - CorMedix Inc. (CRMD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - CorMedix 2.0: New Leadership, New Approval, New Focus - Seeking Alpha